SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma

SIMPLE SUMMARY: The European trial SIOP PNET5 MB was initiated in 2014 and will remain open to recruitment until 2022. It is the first European trial using clinical, histological, and molecular parameters to stratify treatments for childhood medulloblastoma, based on disease risk. In the standard-ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Mynarek, Martin, Milde, Till, Padovani, Laetitia, Janssens, Geert O., Kwiecien, Robert, Mosseri, Veronique, Clifford, Steven C., Doz, François, Rutkowski, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657236/
https://www.ncbi.nlm.nih.gov/pubmed/34885186
http://dx.doi.org/10.3390/cancers13236077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657236/
https://www.ncbi.nlm.nih.gov/pubmed/34885186
http://dx.doi.org/10.3390/cancers13236077

Ejemplares similares